Law enforcement agencies in the Namangan region have reportedly carried out a major operation to suppress the illegal pharmaceutical trade, resulting in the destruction of more than 138,000 bottles and packages of illicitly produced medications with an estimated total value of around 560 million sums. The operation underscores ongoing efforts by local authorities to crack down on the dangerous proliferation of substandard and counterfeit medical products across the country.
Key Takeaways: Authorities in Namangan destroyed 138,031 units of illegal medicines—including iodine, menovazin, and alcohol—along with raw materials and manufacturing equipment, following a formal court ruling regarding a batch valued at approximately 560 million sums.
According to official information provided by the press service of the Bureau of Compulsory Enforcement, the illicit manufacturing operation was uncovered during a raid conducted by the Davlatabad District Department for Combating Economic Crimes. Investigators allegedly discovered that the unregistered products were being manufactured under unhygienic, substandard conditions, posing severe risks to public health and consumer safety.
Pursuant to the relevant court decision, the seized medicines were officially designated as material evidence and ordered for immediate disposal. The execution of the court order was handled by the municipal department of the Bureau of Compulsory Enforcement, with official representatives from specialized organizations supervising the destruction process to ensure full compliance.
The total volume of liquidated items included 40,200 bottles of iodine, 25,680 packages of menovazin, 29,100 units of medical alcohol, 20,100 bottles of hydrogen peroxide, and various other unverified pharmaceutical goods. Furthermore, authorities destroyed 225 kilograms of raw pharmaceutical components, 39,053 packaging containers, and specialized production machinery used to facilitate the illegal enterprise.
This enforcement action forms part of broader systemic measures aimed at curbing the illegal drug trade and safeguarding consumer health. Regulatory bodies are expected to continue targeted inspections and stringent crackdowns against illicit pharmaceutical manufacturers in the foreseeable future.
Source: podrobno.uz